NCT05410314View on ClinicalTrials.gov

Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

February 7, 2020

Primary Completion Date

February 7, 2021

Study Completion Date

December 7, 2021

Conditions
Lymphoma, HodgkinMenstrual IrregularityFertility Disorders
Interventions
DRUG

Myo-Inositol and D-Chiro-Inositol (MIC)

Both groups were followed up for 12 months, in T0 (during first evaluation), and T12 (after twelve months) with blood test for AMH (ng/ml).

Trial Locations (1)

70124

"IRCCS - Istituto OncologicoGiovanni PaoloII", Bari

All Listed Sponsors
lead

University of Bari Aldo Moro

OTHER

NCT05410314 - Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma | Biotech Hunter | Biotech Hunter